Mathilde Chipaux

ORCID: 0000-0002-8454-7374
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Epilepsy research and treatment
  • Pharmacological Effects and Toxicity Studies
  • Neuroscience and Neuropharmacology Research
  • Neonatal and fetal brain pathology
  • EEG and Brain-Computer Interfaces
  • Genomics and Rare Diseases
  • Fetal and Pediatric Neurological Disorders
  • Neural dynamics and brain function
  • Genetics and Neurodevelopmental Disorders
  • Metabolism and Genetic Disorders
  • Neurological disorders and treatments
  • Glioma Diagnosis and Treatment
  • Neuroscience and Neural Engineering
  • Ion channel regulation and function
  • Advanced MRI Techniques and Applications
  • Cancer Genomics and Diagnostics
  • Functional Brain Connectivity Studies
  • Diet and metabolism studies
  • Vascular Malformations Diagnosis and Treatment
  • Advanced biosensing and bioanalysis techniques
  • Tuberous Sclerosis Complex Research
  • Ion Transport and Channel Regulation
  • Cardiovascular Conditions and Treatments
  • Cerebrospinal fluid and hydrocephalus
  • Congenital Heart Disease Studies

Fondation de Rothschild
2016-2025

Institut du Cerveau
2011-2024

University of Geneva
2024

Allen Institute for Brain Science
2024

Sorbonne Université
2011-2024

Amsterdam University Medical Centers
2024

Centre National de la Recherche Scientifique
2011-2024

Assistance Publique – Hôpitaux de Paris
2009-2024

Inserm
2009-2024

Stichting Epilepsie Instellingen Nederland
2024

Genetic malformations of cortical development (MCDs), such as mild MCDs (mMCD), focal dysplasia (FCD), and hemimegalencephaly (HME), are major causes severe pediatric refractory epilepsies subjected to neurosurgery. FCD2 characterized by neuropathological hallmarks that include enlarged dysmorphic neurons (DNs) balloon cells (BCs). Here, we provide a comprehensive assessment the contribution germline somatic variants in large cohort surgical MCD cases. We enrolled monocentric study 80...

10.1007/s00401-019-02061-5 article EN cc-by Acta Neuropathologica 2019-08-23
Herm J. Lamberink Willem M. Otte Ingmar Blümcke Kees P. J. Braun Martin Aichholzer and 95 more Isabel Amorim Javier Aparicio Eleonora Aronica Alexis Arzimanoglou Carmen Barba Jürgen Beck Albert J. Becker Jan Beckervordersandforth Christian G. Bien Ingmar Blümcke István Bódi Kees P. J. Braun Hélène Catenoix Francine Chassoux Mathilde Chipaux Thomas Cloppenborg Roland Coras J. Helen Cross Luca De Palma Jane de Tisi Francesco Deleo Bertrand Devaux Giancarlo Di Gennaro Georg Dorfmüller John S. Duncan Christian E. Elger Katharina Ernst Vincenzo Esposito Martha Feucht Željka Petelin Gadže Rita Garbelli Karin Geleijns António Gil‐Nagel Alexander Grote Thomas Grünwald Renzo Guerrini Hajo M. Hamer Mrinalini Honavar Thomas S. Jacques Antonia Jakovčević Leena Jutila Adam Kalina Reetta Kälviäinen Karl Martin Klein Kristina Koenig Pavel Kršek Manfred Kudernatsch Martin Kudr Herm J. Lamberink Kristina Malmgren Petr Marusič A G Melikyan Katja Menzler Soheyl Noachtar Willem M. Otte Çiğdem Özkara Tom Pieper José Pimentel Savo Raičević Sylvain Rheims Joana Ribeiro Felix Rosenow Karl Rössler Bertil Rydenhag Francisco Sales Victoria San Antonio‐Arce Karl Lothar Schaller Olaf Schijns Theresa O. Scholl Johannes Schramm Andreas Schulze‐Bonhage Raf Sciot Margitta Seeck L V Shishkina Dragoslav Sokić Nicola Specchio Tom Theys Maria Thom Rafael Toledano Joseph Toulouse Mustafa Uzan J. van Loon Wim Van Paesschen Tim J. von Oertzen Floor E. Jansen Frans S.S. Leijten Peter van Rijen Wim G.M. Spliet Angelika Mühlebner Burkhard S. Kasper Susanne Fauser Tilman Polster Thilo Kalbhenn Daniel Delev Andrew W. McEvoy

10.1016/s1474-4422(20)30220-9 article EN The Lancet Neurology 2020-08-18

DEP domain-containing 5 protein (DEPDC5) is a repressor of the recently recognized amino acid-sensing branch mTORC1 pathway. So far, its function in brain remains largely unknown. Germline loss-of-function mutations DEPDC5 have emerged as major cause familial refractory focal epilepsies, with case reports sudden unexpected death epilepsy (SUDEP). Remarkably, fraction patients also develop cortical dysplasia (FCD), neurodevelopmental malformation. We therefore hypothesized that somatic...

10.1172/jci99384 article EN Journal of Clinical Investigation 2018-04-29

PurposeTo define the phenotypic and mutational spectrum of epilepsies related to DEPDC5, NPRL2 NPRL3 genes encoding GATOR1 complex, a negative regulator mTORC1 pathwayMethodsWe analyzed clinical genetic data 73 novel probands (familial sporadic) with epilepsy-related variants in GATOR1-encoding proposed new guidelines for interpretation variants.ResultsThe seizure phenotype consisted mostly focal seizures (e.g., hypermotor or frontal lobe 50%), mean age at onset 4.4 years, often...

10.1038/s41436-018-0060-2 article EN cc-by Genetics in Medicine 2018-08-09

Abstract Focal malformations of cortical development (MCD) are linked to somatic brain mutations occurring during neurodevelopment. Mild malformation with oligodendroglial hyperplasia in epilepsy (MOGHE) is a newly recognized clinico-pathological entity associated pediatric drug-resistant focal epilepsy, and amenable neurosurgical treatment. MOGHE histopathologically characterized by clusters increased cell densities, patchy zones hypomyelination, heterotopic neurons the white matter. The...

10.1186/s40478-020-01085-3 article EN cc-by Acta Neuropathologica Communications 2021-01-06

Abstract Cortical malformations such as focal cortical dysplasia type II (FCDII) are associated with pediatric drug-resistant epilepsy that necessitates neurosurgery. FCDII results from somatic mosaicism due to post-zygotic mutations in genes of the PI3K-AKT-mTOR pathway, which produce a subset dysmorphic cells clustered within healthy brain tissue. Here we show correlation between epileptiform activity acute slices obtained human surgical tissues and density neurons. We uncovered multiple...

10.1038/s41593-024-01634-2 article EN cc-by Nature Neuroscience 2024-05-06

Dravet syndrome (DS) is currently considered as an epileptic encephalopathy, a condition in which epilepsy causes deterioration or developmental delay but preliminary data suggested that cognitive course may worsen independently from epilepsy. Our objective was to prospectively analyze the neuropsychological features large cohort of DS patients and its relationships with SCN1A mutation.81 examinations were performed 67 typical (9m-24y, 15 longitudinally studied) using Brunet-Lezine...

10.1186/1750-1172-8-176 article EN cc-by Orphanet Journal of Rare Diseases 2013-01-01

<h3>Objective:</h3> To assess the prevalence of somatic <i>MTOR</i> mutations in focal cortical dysplasia (FCD) and germline a broad range epilepsies. <h3>Methods:</h3> We collected 20 blood-brain paired samples from patients with FCD searched for variants using deep-targeted gene panel sequencing. Germline were assessed French research cohort 93 probands epilepsies diagnostic Danish 245 Data sharing among collaborators allowed us to ascertain additional <i>MTOR</i>. <h3>Results:</h3>...

10.1212/nxg.0000000000000118 article EN cc-by-nc-nd Neurology Genetics 2016-11-01

Patients with presumed nonlesional focal epilepsy-based on either MRI or histopathologic findings-have a lower success rate of epilepsy surgery compared lesional patients. In this study, we aimed to characterize large group patients who underwent despite normal and had no lesion histopathology. Determinants their postoperative seizure outcomes were further studied.

10.1212/wnl.0000000000208007 article EN Neurology 2024-01-30

We aimed to test the efficacy of ketogenic diet (KD) in patients with Dravet syndrome (DS) not satisfactorily controlled by antiepileptic drugs (AEDs). included prospectively 15 DS aged >3 years partial response AEDs including stiripentol. All had a seizure diary and clinical examination Conners Achenbach scales before KD, at 1 month following onset every 3 months thereafter. At month, 10 (66%) decrease frequency ≥75%. Efficacy was maintained eight responders 6 six 9 months. Five (33%)...

10.1111/j.1528-1167.2011.03107.x article EN Epilepsia 2011-05-13

Aim . We report our experience of stereoelectroencephalography (SEEG) in 65 children with drug‐resistant seizures, a particular emphasis on young children. Methods retrospectively studied all SEEG performed between 2009 and 2011 centre. As can have several indications, the patients were classified into three categories, according to probability surgery. The contribution final decision regarding surgery was evaluated for each category separately. also compared main demographic surgical data...

10.1684/epd.2014.0679 article EN Epileptic Disorders 2014-09-01

Brain mosaic mutations are a major cause of refractory focal epilepsies with cortical malformations such as dysplasia, hemimegalencephaly, malformation development oligodendroglial hyperplasia in epilepsy, and ganglioglioma. Here, we collected cerebrospinal fluid (CSF) during epilepsy surgery to search for somatic variants cell‐free DNA (cfDNA) using targeted droplet digital polymerase chain reaction. In 3 12 epileptic patients known previously identified brain tissue, here provide evidence...

10.1002/ana.26080 article EN Annals of Neurology 2021-04-09

The SLC35A2 gene, located at chromosome Xp11.23, encodes for a uridine diphosphate-galactose transporter. We describe clinical, genetic, neuroimaging, EEG, and histopathologic findings assess possible predictors of postoperative seizure cognitive outcome in 47 patients with refractory epilepsy brain somatic gene variants.This is retrospective multicenter study where we performed descriptive analysis classical hypothesis testing. included the variables interest significantly associated...

10.1212/wnl.0000000000201471 article EN Neurology 2022-10-28

Brain-restricted somatic variants in genes of the mechanistic target rapamycin signalling pathway cause focal epilepsies associated with cortical dysplasia type II. We hypothesized that could be identified from trace tissue adherent to explanted stereoelectroencephalography electrodes used presurgical epilepsy workup localize epileptogenic zone. investigated three paediatric patients drug-resistant subjected neurosurgery. In resected brain tissue, we low-level mosaic mutations AKT3 and...

10.1093/braincomms/fcad174 article EN cc-by Brain Communications 2023-01-01

Abstract Focal cortical dysplasia type II (FCDII) is a malformation causing refractory epilepsy. FCDII arises from developmental somatic mutations in mTOR pathway genes, leading to focal dyslamination and abnormal cytomegalic cells. Which cell types carry pathogenic how they affect cell-type-specific transcriptional programs remains unknown. To address this question, here we combined single-nucleus genotyping transcriptomics morphologically-identified cells using surgical samples...

10.21203/rs.3.rs-4014535/v1 preprint EN cc-by Research Square (Research Square) 2024-03-15

In the premature infant, somatosensory and visual stimuli trigger an immature electroencephalographic (EEG) pattern, "delta-brushes," in corresponding sensory cortical areas. Whether auditory evoke delta-brushes cortex has not been reported. Here, responses to were studied 46 infants without neurologic risk aged 31 38 postmenstrual weeks (PMW) during routine EEG recording. Stimuli consisted of either low-volume technogenic "clicks" near background noise level neonatal care unit, or a human...

10.1371/journal.pone.0079028 article EN cc-by PLoS ONE 2013-11-11

Abstract Focal cortical dysplasia (FCD) and hemimegalencephaly (HME) are related malformations with shared etiologies. We report three patients a spectrum of associated pathogenic brain‐specific somatic Ras homolog enriched in brain ( RHEB) variants. The variant load directly correlated the size malformation, upregulated mTOR activity confirmed dysplastic tissues. Laser capture microdissection showed enrichment RHEB variants dysmorphic neurons balloon cells. Our findings support role...

10.1002/acn3.51286 article EN Annals of Clinical and Translational Neurology 2021-01-12

Lesional focal epilepsy (LFE) is a common and severe seizure disorder caused by epileptogenic lesions, including malformations of cortical development (MCD) low-grade epilepsy-associated tumors (LEAT). Understanding the genetic etiology these lesions can inform medical surgical treatment. We conducted somatic variant enrichment mega-analysis in brain tissue from 1386 individuals who underwent surgery, 599 previously unpublished with ultra-deep ( > 1600x) targeted panel sequencing. Here we...

10.1038/s41467-024-54911-w article EN cc-by-nc-nd Nature Communications 2024-11-30
Coming Soon ...